The fast-food giant behind KFC and Taco Bell reported quarterly sales of $2.51 billion, topping analyst forecasts, but earnings per share came in just below expectations.
A persistent slump in shipping volumes is forcing a painful contraction across the U.S. supply chain, with major retailers, manufacturers, and logistics firms closing facilities and cutting thousands of jobs in early 2026.
GSK reported robust full-year 2025 results, with sales exceeding £32 billion and profit growth outpacing revenue. Executives outlined a 2026 strategy focused on maximizing recent drug launches, accelerating late-stage pipeline assets, and leveraging technology, while navigating currency headwinds and a profit shift to the second half.
U.S. equity futures edged higher Wednesday after Washington moved to reopen the federal government, shifting investor attention to a heavy slate of corporate earnings led by tech giant Alphabet.
Reynolds Consumer Products (NASDAQ: REYN) reported fourth-quarter sales that surpassed analyst expectations, though a weaker-than-anticipated revenue forecast for the coming quarter highlights ongoing challenges in volume growth for the household staples maker.
Bitcoin and Ether claw back some losses following a sharp sell-off, though derivatives data suggests traders remain cautious. The bounce coincides with a broader market relief rally spurred by U.S. fiscal developments.
A devastating incident on the outskirts of New Delhi has claimed the lives of three teenage sisters, with preliminary investigations pointing to a severe reaction after their parents removed their access to an online game.
A new Congressional Budget Office analysis reveals the staggering financial cost of deploying troops to American cities, raising profound questions about policy, politics, and civil-military boundaries.
GSK's annual net profit more than doubled in 2025, fueled by robust sales of HIV, respiratory, and oncology medicines. The results signal a strong recovery for the pharma giant after settling costly U.S. lawsuits related to its discontinued heartburn drug Zantac.
Morgan Stanley's robust fourth-quarter performance, led by a resurgent investment banking division and stable wealth management, has reignited investor interest and sparked fresh analysis on whether its current stock price fully reflects future prospects.
A surge in late self-assessment payments has resulted in a £325 million windfall for HMRC in penalties and interest, with experts warning the tax authority shows no sign of leniency as unpaid liabilities mount.
Ahold Delhaize's latest fair value estimate sees a marginal adjustment, yet the gap between bullish and bearish analyst targets remains wide. Behind the numbers, subtle changes in discount rates and growth forecasts signal an ongoing debate over the retail giant's resilience in a challenging market.
Darden Restaurants is permanently closing all remaining Bahama Breeze locations, with half the sites to be converted to other brands in its portfolio, citing competitive pressures and operational challenges.
American Airlines confronts the costly aftermath of Winter Storm Fern, its largest weather disruption ever, with over 9,000 flights canceled. As the carrier works to recover, its long-term focus remains on expanding premium cabins, loyalty programs, and key hubs to drive future profitability.
After a challenging 2025, e.l.f. Beauty's stock saw a significant rebound last month, driven by favorable tariff adjustments and growing sentiment that the market may have undervalued the resilient cosmetics disruptor.
HP Inc. faces a period of unexpected leadership change as CEO Enrique Lores departs for PayPal. With interim CEO Bruce Broussard at the helm and a search underway, the company reaffirms its 2026 earnings outlook, signaling stability amidst uncertainty for the PC and printing giant.
GE HealthCare Technologies posted stronger-than-expected fourth-quarter revenue of $5.70 billion, a 7.1% year-over-year increase, while adjusted earnings per share of $1.44 also edged past analyst consensus. The performance highlights steady demand for its medical imaging and pharmaceutical diagnostics units amid ongoing healthcare capital investment.
Ethereum co-founder Vitalik Buterin's recent comments questioning the original vision for Layer 2 solutions have ignited a fierce debate. As transaction costs plummet on the mainnet, the fundamental value proposition of many L2s is under scrutiny, raising questions about Ethereum's competitive edge and long-term trajectory.
UBS Group's stock tumbled following a stark slowdown in net new asset growth at its key U.S. wealth management business, with executives warning of persistent challenges ahead even as the bank posts higher quarterly profit.
As Bitcoin's price struggles to find a floor, analysts point to a critical and seemingly calm indicator—the US corporate credit spread—as the potential trigger for the next major move. The current divergence between compressed credit risk and falling crypto prices suggests markets may be underpricing looming stress.
